Haqq Christopher
Insider CIK 1612095 · ELTX See Remarks · ATRA EVP, R&D & Chief Scientific Of · SRZN
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-07-16 | 2026-07-17 | 64,643 | — | $0 | 64,643 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-03 | 50,900 | — | $0 | 50,900 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-03 | 25,400 | — | $0 | 57,381 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2024-09-30 | 2024-10-02 | 28,200 | — | $0 | 28,200 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 28,200 | — | $0 | 28,200 | SEC↗ |
| SRZN Surrozen, Inc./DE | D To issuer deriv | 2021-08-11 | 2021-08-13 | 30,000 | — | $0 | 0 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award | 2021-08-11 | 2021-08-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2019-02-15 | 2019-02-19 | 775 | $39.59 | $30.7K | 271,943 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2019-02-11 | 2019-02-11 | 13,975 | $38.55 | $538.7K | 272,718 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2019-02-06 | 2019-02-08 | 9,698 | $38.78 | $376.1K | 273,205 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2019-02-06 | 2019-02-08 | 2,677 | $38.04 | $101.8K | 282,903 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 15,000 | — | $0 | 286,693 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2019-02-06 | 2019-02-08 | 1,512 | $38.47 | $58.2K | 271,693 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-11-15 | 2018-11-15 | 775 | $33.81 | $26.2K | 285,580 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-09-26 | 2018-09-27 | 13,500 | $43.08 | $581.6K | 286,355 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-09-25 | 2018-09-25 | 3,500 | $41.23 | $144.3K | 299,855 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-09-25 | 2018-09-25 | 10,000 | $40.26 | $402.6K | 303,355 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-09-24 | 2018-09-25 | 14,069 | $39.74 | $559.1K | 317,286 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-09-24 | 2018-09-25 | 3,931 | $40.53 | $159.3K | 313,355 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-08-15 | 2018-08-16 | 775 | $37.54 | $29.1K | 331,355 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2018-05-15 | 2018-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-05-15 | 2018-05-16 | 6,885 | $44.44 | $306.0K | 351,020 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-05-15 | 2018-05-16 | 9,638 | $45.21 | $435.7K | 341,382 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-05-15 | 2018-05-16 | 9,252 | $46.02 | $425.8K | 332,130 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2018-05-15 | 2018-05-16 | 25,000 | $11.00 | $275.0K | 357,905 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-03-26 | 2018-03-27 | 17,227 | $39.76 | $684.9K | 334,005 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-03-26 | 2018-03-27 | 1,100 | $40.29 | $44.3K | 332,905 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2018-02-15 | 2018-02-20 | 553 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2018-02-15 | 2018-02-20 | 553 | — | $0 | 351,232 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2018-02-09 | 2018-02-12 | 4,925 | $41.70 | $205.4K | 350,679 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-02-06 | 2018-02-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2018-02-06 | 2018-02-08 | 4,426 | $35.80 | $158.5K | 355,604 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-02-06 | 2018-02-08 | 17,500 | — | $0 | 360,030 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-11-15 | 2017-11-17 | 829 | — | $0 | 553 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-11-15 | 2017-11-17 | 829 | — | $0 | 344,134 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-11-15 | 2017-11-17 | 1,604 | $13.36 | $21.4K | 342,530 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-10-16 | 2017-10-17 | 6,000 | $14.35 | $86.1K | 343,305 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-09-15 | 2017-09-18 | 6,000 | $15.30 | $91.8K | 349,305 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-08-15 | 2017-08-17 | 829 | — | $0 | 1,382 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-08-15 | 2017-08-17 | 829 | — | $0 | 362,909 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-08-15 | 2017-08-17 | 7,604 | $14.75 | $112.2K | 355,305 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-07-17 | 2017-07-18 | 6,000 | $14.92 | $89.5K | 362,080 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-06-15 | 2017-06-16 | 6,000 | $12.65 | $75.9K | 368,080 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-05-15 | 2017-05-17 | 829 | — | $0 | 2,211 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-05-15 | 2017-05-17 | 7,604 | $14.99 | $114.0K | 374,080 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-05-15 | 2017-05-17 | 829 | — | $0 | 381,684 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-04-17 | 2017-04-19 | 6,000 | $17.28 | $103.7K | 380,855 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-03-15 | 2017-03-17 | 6,000 | $19.60 | $117.6K | 386,855 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-02-15 | 2017-02-16 | 829 | — | $0 | 3,040 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-02-15 | 2017-02-16 | 7,604 | $15.49 | $117.8K | 392,855 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-02-15 | 2017-02-16 | 829 | — | $0 | 400,459 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-02-09 | 2017-02-10 | 13,975 | $15.46 | $216.1K | 399,630 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2017-02-06 | 2017-02-08 | 49,500 | — | $0 | 413,605 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-01-17 | 2017-01-18 | 6,000 | $14.27 | $85.6K | 364,105 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-12-15 | 2016-12-15 | 6,000 | $15.40 | $92.4K | 370,105 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-11-21 | 2016-11-22 | 7,068 | $17.85 | $126.2K | 376,105 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-11-15 | 2016-11-17 | 829 | — | $0 | 3,869 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-11-15 | 2016-11-17 | 1,604 | $19.95 | $32.0K | 383,173 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-11-15 | 2016-11-17 | 829 | — | $0 | 384,777 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2016-09-22 | 2016-09-23 | 90,000 | — | $0 | 383,948 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-08-15 | 2016-08-17 | 829 | — | $0 | 4,698 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-08-15 | 2016-08-17 | 829 | — | $0 | 295,294 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-08-15 | 2016-08-17 | 400 | $21.70 | $8.7K | 294,894 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-08-15 | 2016-08-17 | 946 | $22.58 | $21.4K | 293,948 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-05-16 | 2016-05-18 | 830 | — | $0 | 5,527 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-05-16 | 2016-05-18 | 830 | — | $0 | 296,070 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-05-16 | 2016-05-18 | 1,605 | $15.57 | $25.0K | 294,465 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-02-16 | 2016-02-18 | 829 | — | $0 | 6,357 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-02-16 | 2016-02-18 | 3,208 | $15.43 | $49.5K | 295,240 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-02-16 | 2016-02-18 | 829 | — | $0 | 298,448 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2016-02-09 | 2016-02-11 | 55,900 | — | $0 | 297,619 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2015-12-17 | 2015-12-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-11-16 | 2015-11-18 | 829 | — | $0 | 7,186 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-11-16 | 2015-11-18 | 829 | — | $0 | 241,719 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-31 | 2015-09-01 | 3,900 | $42.10 | $164.2K | 240,890 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-31 | 2015-09-01 | 1,100 | $41.61 | $45.8K | 244,790 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-08-17 | 2015-08-19 | 829 | — | $0 | 8,015 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-17 | 2015-08-19 | 300 | $46.58 | $14.0K | 245,890 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-08-17 | 2015-08-19 | 829 | — | $0 | 247,494 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-17 | 2015-08-19 | 1,304 | $45.75 | $59.7K | 246,190 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-07-31 | 2015-08-03 | 2,500 | $55.43 | $138.6K | 246,665 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-07-15 | 2015-07-15 | 800 | $63.39 | $50.7K | 249,165 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-07-15 | 2015-07-15 | 1,700 | $62.73 | $106.6K | 249,965 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-07-01 | 2015-07-02 | 1,300 | $52.36 | $68.1K | 251,665 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-07-01 | 2015-07-02 | 1,200 | $50.94 | $61.1K | 252,965 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-06-15 | 2015-06-16 | 1,100 | $47.34 | $52.1K | 254,165 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-06-15 | 2015-06-16 | 6,100 | $46.34 | $282.7K | 255,265 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-06-15 | 2015-06-16 | 300 | $44.56 | $13.4K | 261,365 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-06-01 | 2015-06-01 | 700 | $41.68 | $29.2K | 262,115 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-06-01 | 2015-06-01 | 450 | $42.68 | $19.2K | 261,665 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-06-01 | 2015-06-01 | 1,350 | $40.95 | $55.3K | 262,815 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-05-15 | 2015-05-19 | 4,422 | — | $0 | 8,844 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-05-15 | 2015-05-19 | 4,422 | — | $0 | 266,052 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | F Tax w/h | 2015-05-15 | 2015-05-19 | 1,887 | $37.30 | $70.4K | 264,165 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-01-16 | 2015-01-21 | 41,333 | — | $0 | 41,333 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2015-01-16 | 2015-01-21 | 12,400 | — | $0 | 261,630 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2014-10-21 | 2014-10-23 | 13,266 | — | $0 | 13,266 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2014-10-15 | 2014-10-16 | 50,000 | — | $0 | 50,000 | SEC↗ |